SOX10 and primitive neuroectodermal tumor: However, the combination of strong immunopositivity for both, SOX10 and ANKRD55 proved highly specific for CNS_NBL, both in institutionally diagnosed CNS-PNET cohort and extended set of malignant pediatric brain tumors.